Fibromyalgia & Other Clinical Pain Syndromes Poster

Poster session.

Presentations:

• 9:00 AM – 11:00 AM ET

  Association Between Changes in Pain Sensitization and Changes in Disease Activity After 12 Weeks of Disease Modifying Anti-Rheumatic Drug Therapy in Rheumatoid Arthritis
  Andrew Heisler, MD – Northwestern University Feinberg School of Medicine
• 9:00 AM – 11:00 AM ET

  Hypophosphatasia May Be Misdiagnosed as Fibromyalgia: A Single Center Experience
  Patil Injean, DO – Loma Linda University Medical Center
• 9:00 AM – 11:00 AM ET

  An International Delphi Consensus on Non-pharmacological Interventions for Fibromyalgia
  Burak Kundakci, MSc – University of Nottingham
• 9:00 AM – 11:00 AM ET

  Clinical and Psychological Assessment of Rheumatoid Arthritis Patients with Fibromyalgia: A Real World Study
  Tian Liu, MD – Department of Rheumatology and Immunology, Peking University People's Hospital
• 9:00 AM – 11:00 AM ET

  A Modified Version of the 2016 ACR Fibromyalgia Criteria Cognitive Items Results in Stronger Correlation Between Subjective and Objective Measures of Cognitive Impairment
  Valerie Aloush, MD – Tel Aviv Medical Center
• 9:00 AM – 11:00 AM ET

  CYP2D6 Genotype and Reduced Codeine Analgesic Effect in Real-World Clinical Practice
  Cecilia P. Chung, MD, MPH – Vanderbilt University Medical Center
• 9:00 AM – 11:00 AM ET

  Pain in the Time of Corona: Impact of COVID 19 Outbreak on Fibromyalgia Patients
  Valerie Aloush, MD – Tel Aviv Medical Center